Press release
Breast Cancer Drugs Market Size, Share, Growth, Research and Forecast 2019-2025
Rising prevalence of breast cancers globally is soaring the global breast cancer drugs market size. As per the World Health Organization, in 2018, breast cancer had the largest number of new cancer incidences. In 2018, the reported number of new breast cancer incidences was 234,087, which accounted for 11% of all new cancer incidences. As of January 2019, there were 16.9 million survivors in the US, which is expected to reach 21.7 million by 2029 (National Cancer Institute). Radiation therapy is one of the primarily used treatments for cancer. It can be given to cure cancer, either alone or in combination with surgery and/or chemotherapy. Breast, lung, and prostate cancer patients consist of over half of all patients receiving radiation therapy.A full report of Breast Cancer Drugs Market is available at: https://www.omrglobal.com/industry-reports/breast-cancer-drugs-market
Increasing FDA approvals for personalized medicine is further promising ample growth opportunities for the market
The increasing adoption of personalized medicines for cancer treatment is furthermore augmenting the growth of the breast cancer drugs market. Increasing FDA approvals for personalized medicines are supporting to drive the growth of the market in the region. For instance, as per the Personalized Medicine Coalition, in 2018, 25 of the 59 new molecular entities (NMEs) FDA approved are personalized medicines, which is 42% of all new drug approvals. The coalition classified 34% of NMEs as personalized medicines in 2017, 28% in 2015; 27% in 2016. A significant number of cancer precision medicines approved in 2018, which includes biosimilars, Truxima (rituximab-abbs) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin lymphoma (NHL), and Herzuma (trastuzumab-pkrb), as a biosimilar to Herceptin for the treatment of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer and metastatic gastric cancer.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/breast-cancer-drugs-market
Asia-Pacific to gain maximum traction over the forecast period
Asia-Pacific is expected to witness the fastest growth rate in the global breast cancer industry over the forecast period. Increasing prevalence of breast cancer coupled with the improving healthcare infrastructure is influencing the regional market growth. The increasing number of breast cancer patients reflects the need for the therapies including drugs for the treatment of breast cancer. As per American Cancer Society, breast cancer, lung and bronchus cancer, stomach cancer, colorectum cancer, and esophagus cancer are the most common cancer diagnosed in women, accounting for around 60% of all cases in China.
Moreover, 15% of all new cancer incidences in women accounted for breast cancer, making it the most severe health condition for women in China.
Further, according to the Indian Council of Medical Research, around 1.7 million new cases of cancer are expected to emerge that are projected to take over 800,000 lives by 2020. The major mortalities in India are due to cancer which constitutes to Lung and oral among males and breast and cervix in females. Breast cancer in females accounts for more than 50% of all cancer deaths in India. Breast cancer is most prevalent in women with oral cancer being more common in males. The north-eastern states of India reported the maximum number of cancer cases. As per National Institute of Cancer Prevention and Research (NICPR), the breast cancer cases reported in India accounted to 10% of all cancers that was around 150,000 new incidences in 2016.
Current Market Trends Covered in the Global Breast Cancer Drugs Market Report
• Based on the drug class type, the immunotherapy segment is estimated to hold a significant market share during the forecast period.
• Based on the geography, North America is estimated to dominate the global breast cancer drugs market during the forecast period.
• Asia-Pacific is anticipated to register the fastest growth in the global breast cancer drugs industry during the forecast period.
Global Breast Cancer Drugs Market Segmentation
By Drug Class Type
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/breast-cancer-drugs-market
Global Breast Cancer Drugs Market – Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• AbbVie Inc.
• AstraZeneca PLC
• Biocon Ltd.
• BioNumerik Pharmaceuticals, Inc.
• Celgene Corp.
• Celldex Therapeutics
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Genzyme Corp.
• Johnson & Johnson Services Inc.
• MacroGenics Inc.
• Merck & Co., Inc.
• Novartis AG
• Onyx Pharmaceuticals Inc.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Drugs Market Size, Share, Growth, Research and Forecast 2019-2025 here
News-ID: 2208281 • Views: …
More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…